Drug Labeling and Warnings

Drug Details

k">

TRIAMCINOLONE-MOXIFLOXACIN PF- triamcinolone-moxifloxacin pf injection, suspension 
Imprimis NJOF, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Store at 20° to 25° C (68° to 77° F)

Package Label

Package Label

TRIAMCINOLONE-MOXIFLOXACIN PF 
triamcinolone-moxifloxacin pf injection, suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 71384-510
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA) TRIAMCINOLONE ACETONIDE15 mg  in 1 mL
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE (UNII: B8956S8609) (MOXIFLOXACIN - UNII:U188XYD42P) MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE1 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 71384-510-0120 in 1 BOX01/05/2018
10.6 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/05/2018
Labeler - Imprimis NJOF, LLC (080431967)
Registrant - Imprimis NJOF, LLC (080431967)
Establishment
NameAddressID/FEIBusiness Operations
Imprimis NJOF, LLC080431967manufacture(71384-510)

Revised: 1/2018
 
Imprimis NJOF, LLC


© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.